Skip to main content

Baltic Horizon Fund plans to redeem early part of the bonds

Baltic Horizon Fund is proceeding with the execution of its plan to reduce bond exposure and will redeem the fifth part of Baltic Horizon Fund EUR 42 million 5-year floating rate bonds maturing in 2028 (ISIN EE3300003235, the Bonds) in the total nominal amount of EUR 7,499,998.80 on 31 March 2026. The redemption is planned to be carried out by way of decreasing the nominal value of the Bonds and the new nominal value would be EUR 27,380.95 per Bond. The amount payable to investors per one Bond is EUR 18,727.74, including redemption payment and accrued but unpaid interest. The total nominal amount of the Bonds before the redemption is EUR 18,999,997.80 and after the redemption would be EUR 11,499,999. The list of bondholders will be fixed at the end of the working day of the Nasdaq CSD settlement system on 24 March 2026. For additional...

Continue reading

Sun Cruiser to Become Official Ready-to-Drink Cocktail of the U.S. Open and U.S. Women’s Open Presented by Ally

National partnership will debut during the USGA’s 2026 championship seasonSun Cruiser to Become Official Ready-to-Drink Cocktail of the U.S. Open and U.S. Women’s Open Presented by AllyNational partnership will debut during the USGA’s 2026 championship seasonBOSTON, March 10, 2026 (GLOBE NEWSWIRE) — Sun Cruiser, the fast-growing vodka iced tea brand made by The Boston Beer Company, and the USGA today announced a multi-year partnership, making Sun Cruiser the Official Ready-to-Drink Cocktail of two of golf’s most notable championships, the U.S. Open and U.S. Women’s Open Presented by Ally. The newly launched national partnership will see Sun Cruiser integrated into the USGA’s two flagship championships through on-site activations and in hospitality spaces, while Sun Cruiser will help promote the championships across...

Continue reading

Data Storage Corporation Schedules Fiscal 2025 Business Update Call

NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) — Data Storage Corporation (Nasdaq: DTST) (“DSC” and the “Company”), today announced plans to host a business update conference call at 11:00 a.m. Eastern Time on March 31, 2026, to discuss the Company’s financial results for the 2025 fiscal year which ended December 31, 2025, as well as corporate progress and other developments. The conference call will be available via telephone by dialing toll-free 877-407-9219 for U.S. callers or for international callers +1-412-652-1274. A webcast of the call may be accessed at  DTST Business Update Call or on the Company’s News & Events section of the website,  www.dtst.com/news-events. A webcast replay of the call will be available on the Company’s website (www.dtst.com/news-events) through September 30, 2026. A telephone replay of the...

Continue reading

Goliath Resources Acquires 100% Ownership Of The Golddigger Property Hosting The High-Grade Surebet Gold Discovery And Buys Down 1% Of The NSR, Golden Triangle, B.C.

TORONTO, March 10, 2026 (GLOBE NEWSWIRE) — Goliath Resources Limited (TSX-V: GOT) (OTCQX: GOTRF) (Frankfurt: B4IF) (the “Company” or “Goliath“), further to its press release dated January 22, 2026 (the “Prior Press Release”), is very pleased to announce that it has received TSX Venture Exchange (“TSXV”) approval and has issued 3,000,000 common shares (the “Consideration Shares”) to The J2 Syndicate and J2 Syndicate Holdings Ltd. (the “Optionors”) pursuant to an amending agreement dated January 21, 2026 (the “Amending Agreement”) which amends its existing property option agreement with the Optionors (the “Option Agreement”) in respect of its Golddigger Property located in the Golden Triangle, B.C., which hosts the high-grade Surebet Gold Discovery. The Consideration Shares have a four month plus one day hold...

Continue reading

SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails

TEL AVIV, Israel, March 10, 2026 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) (“NeuroThera”), a clinical-stage pharmaceutical company focused on developing novel treatments for central nervous system disorders, in which SciSparc holds a controlling interest of approximately 75%, has entered into a definitive share purchase agreement (the “SPA”), between NeuroThera, CliniQuantum Ltd. (“CliniQ”) and the Selling Shareholders (as defined below) to acquire approximately 54.01% of the issued and outstanding ordinary shares of CliniQ (the “CliniQ Shares”) on a fully diluted basis immediately prior to the closing of the transaction (the “Transaction”). CliniQ is a quantum technology company holding patents from Ramot...

Continue reading

Cosmos Health Enters into LOI to Acquire $11,500,000 Pharmacy Distribution Network; Remains on Track to Deliver 2027 Revenue Guidance of $155,800,000

CHICAGO, Ill., March 10, 2026 (GLOBE NEWSWIRE) — Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has entered into a Letter of Intent (“LOI”), through its wholly owned subsidiary CosmoFarm S.A. (“CosmoFarm”), with respect to the acquisition of an extensive pharmacy distribution network from an established pharmaceutical company serving the Greek market for almost 40 years. The term of the LOI is ninety (90) days from March 6, 2026. The network currently generates approximately €10 million (approximately $11.5 million based on the prevailing EUR/USD exchange rate) in annual gross revenue and serves a broad base of pharmacy customers, supplying both pharmaceutical and para-pharmaceutical products. The acquisition...

Continue reading

Global Mofy Integrates OpenClaw AI Agent Framework into Core Production Pipeline, Powering Its AI-Driven Content Production Strategy

BEIJING, March 10, 2026 (GLOBE NEWSWIRE) — Global Mofy AI Limited (the “Company” or “Global Mofy”) (Nasdaq: GMM), a generative AI-driven technology solutions provider engaged in virtual content production and the development of 3D digital assets, today announced that it has completed the deployment and integration of the open-source AI agent framework OpenClaw into its internal core content production workflows. This implementation marks an important step forward in the Company’s AIGC (Artificial Intelligence Generated Content) production infrastructure and lays a technological foundation for its next phase of AI-driven content production strategy. As generative AI evolves from standalone tools toward integrated production systems, demand for more automated and scalable content creation capabilities continues to grow across the...

Continue reading

VivoPower Announces New Stock Ticker “VIVO” and Corporate Name Change in Alignment with its Business Focus on AI Data Centers

LONDON, March 10, 2026 (GLOBE NEWSWIRE) — VivoPower International PLC (Nasdaq: VVPR) (“VivoPower” or the “Company”), a leading B Corp-certified global developer and owner of powered land and data center infrastructure for AI compute applications, today announced that, effective March 16, 2026, before the open of trading on the Nasdaq stock market, its stock will be traded under the ticker “VIVO”. The Company has also changed its name to VivoPower PLC. Both changes reflect the Company’s business focus on building, owning, and leasing powered land and data center infrastructure for AI compute applications. The name change does not affect the rights of shareholders, and no action is required from current shareholders. VivoPower’s scope is land, power, and real-estate infrastructure, with technology and operations...

Continue reading

Silynxcom Receives Approximately $100,000 Order for Elite Military Units in the Middle East

Netanya, Israel, March 10, 2026 (GLOBE NEWSWIRE) — Silynxcom Ltd. (NYSE American: SYNX) (“Silynxcom” or the “Company”), a manufacturer and developer of ruggedized tactical communication headset devices, today announced that it has received two purchase orders for approximately $100,000 from elite military units in the Middle East for the Company’s maintenance services. The current service orders are part of a framework contract with these customers and follow previous orders placed by these units for the Company’s advanced tactical systems. The Company continues to solidify its position among leading defense organizations and elite units seeking advanced and innovative tactical equipment for defense and communication. Silynxcom’s tactical systems provide combat-proven awareness and seamless radio connectivity in some of the world’s...

Continue reading

DrChrono Expands AI Capabilities with Launch of EverHealth Scribe Ambient Documentation Solution

EverHealth Scribe users report saving an average of 8 minutes of clinical documentation time per visit and 32% increase in same-day claim submissions DENVER, March 10, 2026 (GLOBE NEWSWIRE) — EverCommerce’s (Nasdaq: EVCM) healthcare business unit EverHealth today announced the launch of EverHealth Scribe, a new AI-powered ambient documentation technology embedded in DrChrono by EverHealth, an all-in-one Electronic Health Record (EHR) platform. EverHealth Scribe is designed to reduce the burden of clinical documentation by listening to provider–patient conversations and automatically generating compliant, structured visit notes within the EHR, ready for provider review and approval. “This launch reflects our commitment to delivering smarter, AI-powered solutions that focus on creating tangible provider and patient outcomes,” said...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.